13F Insight
DOSSIER · 13F-HR · Q2 2026

PZENA INVESTMENT MANAGEMENT LLC

$34.1B in tracked AUM across 195 positions as of Q2 2026.

PI
CIK 0001027796 · last filed Jun 30, 2026
Total AUM
$34.1B
as of Q2 2026
Holdings
195
—
positions
Whale Score
71
71
strong
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

PZENA INVESTMENT MANAGEMENT LLC filed Q1 2026 13F-HR with $30.8B in disclosed U.S. equity holdings The portfolio is led by Consumer Cyclical exposure, with top positions including MGA (6.4%), CTSH (4.0%), TSN (3.6%). Quarter-over-quarter activity shows 6 new entries and 6 exits, with a net reductive posture across 56 changed positions. Notable reduction: DG (35.4% reduction) (DOLLAR GEN CORP).

PZENA INVESTMENT MANAGEMENT LLC reports $30.8B in U.S. equity holdings for Q1 2026, anchored by a Consumer Cyclical-centric allocation. The top five positions by value span MGA + CTSH + TSN + BAX + BMY, collectively representing a meaningful concentration within the disclosed book.

Core Holdings

  • MGA (MAGNA INTL INC) — $2.0B (6.4%)
  • CTSH (COGNIZANT TECHNOLOGY SOLUTIO) — $1.2B (4.0%)
  • TSN (TYSON FOODS INC) — $1.1B (3.6%)
  • BAX (BAXTER INTL INC) — $1.1B (3.5%)
  • BMY (BRISTOL-MYERS SQUIBB CO) — $1.0B (3.4%)
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
MGA
MAGNA INTL INC
$2.2B23.9M6.5%02
HUM
HUMANA INC
$1.7B4.4M5.1%03
BAX
BAXTER INTL INC
$1.4B65.3M4.1%04
CVS
CVS HEALTH CORP
$1.2B11.8M3.6%05
DG
DOLLAR GEN CORP
$1.2B10.2M3.5%06
SWKS
SKYWORKS SOLUTIONS INC
$1.1B16.0M3.2%07
CTSH
COGNIZANT TECHNOLOGY SOLUTIO
$1.0B26.5M3.0%08
BMY
BRISTOL-MYERS SQUIBB CO
$980M17.0M2.9%09
TSN
TYSON FOODS INC
$974M17.0M2.9%10
CRBG
COREBRIDGE FINL INC
$967M33.8M2.8%

Filing history

2026Q2Jun 30
$34.1B▲ 10.6%
195 positionsView →2026Q1Mar 31
$30.8B▼ 7.8%
192 positionsView →2025Q4Dec 31
$33.4B▲ 8.0%
189 positionsView →2025Q3Sep 30
$30.9B▲ 0.6%
186 positionsView →2025Q2Jun 30
$30.8B▲ 7.4%
184 positionsLocked2025Q1Mar 31
$28.6B▼ 2.5%
178 positionsLocked2024Q4Dec 31
$29.4B▼ 5.3%
184 positionsLocked2024Q3Sep 30
$31.0B▲ 9.1%
191 positionsLocked2024Q2Jun 30
$28.4B▼ 2.4%
194 positionsLocked2024Q1Mar 31
$29.1B▲ 9.5%
220 positionsLocked2023Q4Dec 31
$26.6B▲ 14.3%
222 positionsLocked2023Q3Sep 30
$23.3B▼ 0.7%
165 positionsLocked
Showing 12 of 85